The Reviewers at Crowdacure

Julian Gold

Julian Gold is a Professor at The Albion Centre, Prince of Wales Hospital, Sydney and at Queen Mary University of London, based at The Royal London Hospital, Whitechapel. He qualified in Medicine at University of Sydney and completed post-graduate training at University College Hospital, London School of Hygiene and Tropical Medicine and as an Epidemic Intelligence Service Officer at The U.S. Centers for Disease Control in Atlanta. His PhD thesis was on the epidemiology of HIV/AIDS in Australia where he established the original national AIDS surveillance system. Currently, he is a clinician and academic, managing patients with infectious diseases, and Director of the WHO Regional Collaborating Centre for HIV/AIDS, responsible for healthcare worker training and capacity building in Southeast Asia. His research interests, in addition to clinical trials of new anti-retroviral therapies for HIV, are in the possible viral aetiology of Multiple Sclerosis and the role of endogenous retroviruses as a cause or trigger for autoimmune diseases and some cancers. As principal investigator of the INSPIRE study, he co-leads a team to study the possible role of HIV anti-retroviral therapies as a treatment for Multiple Sclerosis. He divides his time between London and Sydney, much of which is spent at 35,000ft followed by extended periods of jet-lag.

The Albion Centre, Prince of Wales Hospital Sidney, Australia; Queen Mary University of London, The Royal London Hospital, Whitechapel, UK

Gary Cutter

Gary Cutter,  MS Ph.D.  Dr. Cutter is a Professor of Biostatistics, Department of Biostatistics, in the Section on Research Methods and Clinical Trials (RMCT Section) at the UAB School of Public Health.  Dr. Cutter has a major interest in design, analysis and interpretation of clinical trials, epidemiologic studies and evaluation research and has a heavy focus on MS.  He directs several coordinating centers; the recently completed CombiRx Trial of combination therapy in MS; the ongoing C/SOAP (Csection antibiotic trial) and Chronic Hypertension in Pregnancy Trials; is Principal Investigator of the multinational MGTX - a surgical trial in Myasthenia Gravis and directs its coordinating Center; and is the director of the data center for the NARCOMS registry of over 37,000 MS patients funded by the Consortium of MS Centers and private sources.

He is Deputy Director of the Operations Center for the Neurofibromatosis Consortium and the Director, Biostatistics/Bioinformatics Resource (BBR) Core for the Obrien Center for Acute Kidney Injury Research, UAB-USC (NIDDK) and Director, Center For Aids Research, Biostatistics Core, UAB (NIAID).  He is a member of numerous data and safety monitoring committees for the NIH, Pharmaceutical Companies and foundations.  He is on the editorial board of the Multiple Sclerosis Journal and contributing editor to Neurology: Clinical Practice and is the statistical reviewer for many other journals. He has been active in the evaluation of outcome measures in MS and was instrumental in the development of the Multiple Sclerosis Functional Composite and a contributing member to the Multiple Sclerosis Outcomes Assessment Consortium (MSOAC), an academic/industry initiative to improve and obtain acceptance by FDA of outcome measures in MS.  He is currently the President Elect of the Consortium of MS Centers.

Chairman of Crowdacure Peer Review Committee; Professor of Biostatistics, Department of Biostatistics, University of Birmingham, Alabama, UAB School of Public Health; Birmingham, Alabama, USA

Diego Centonze

Diego Centonze is Full Professor of Neurology at the Department of Systems Medicine and head of the UOSD Multiple Sclerosis Clinical and Research Center at Tor Vergata Hospital. He leads the Laboratory for non-invasive brain stimulation at Tor Vergata Hospital, the Experimental Neurology Laboratory at Tor Vergata University and the Neuroimmunology and Synaptic Plasticity Laboratory at Fondazione Santa  Lucia/CERC in Rome. His major clinical interest involves the evaluation of new drugs for the treatment of MS. His research interests are related to the role of synaptic transmission and plasticity in the pathophysiology of Multiple Sclerosis and of its experimental model, and to the physiology of the endocannabinoid system and its involvement in inflammatory
neurodegenerative diseases.

Prof. Centonze graduated in Medicine at the University of Rome La Sapienza in 1994, specialised in Neurology in 1999 and in Psychiatry in 2006 at the University of Rome Tor Vergata. He obtained his PhD in Rehabilitation Medicine in 2012. He is Principal Investigator of manyphase II, III and IV national and international trials with new therapeutic agents for MS. He is also Expert Consultant of the European Medicine Agency for MS. He is Member of the Society for Neuroscience, the Italian Neurological Society (SIN) and the Italian Neuroscience Society (SINS). Prof. Centonze is author of around 290 peer-reviewed papers published in international journals of Neuroscience, Neurology and Psychiatry.

University of Rome Tor Vergata, Rome, Italy

Hilla Shaviv

M.Sc. – Bio-Fluid dynamics expert, over 15 years of medical devices R&D experience. B.Sc. Caltech Mechanical & Fluid Dynamics Engineering, M.Sc. Tel-Aviv University (Biomedical Engineering).

Galmedics Jerusalem, Israel

Bartlomiej Piechowski-Jozwiak

Bart is an active clinician and researcher in the field of Vascular Neurology. He graduated from the Medical University of Warsaw and he did several subspecialty fellowships in Vascular Neurology in leading Global Centres such as Helsinki University and Centre Hospitalier Universitaire Vaudois in Lausanne. He works as a consultant neurologist at King's College Hospital and he is an active member of Research Advisory Group for Neuroscience there and also a local Principal Investigator in Clinical Research Network studies. He has experience in opening research centres and implementing clinical research into daily clinical practice.

King's College Hospital London, UK

Please reload


Gary C Sieck

Gary C. Sieck, Ph.D., is the Vernon F. and Earline D. Dale Professor of Physiology & amp;
Biomedical Engineering at Mayo Clinic and a Mayo Distinguished Investigator. He served as
Chair of the Department of Physiology and Biomedical Engineering from 2002-2014, Dean for
Research Academic Affairs from 2006-2012 and Director of the Biomedical Engineering
Program in the Mayo Graduate School from 2001-2013. 
Dr. Sieck received a Ph.D. in
Physiology and Biophysics from the University of Nebraska Medical Center in 1976. He then
completed postdoctoral training in Neurophysiology at UCLA in 1979, where he continued as a
faculty member in the Department of Anatomy and Cell Biology. In 
1987, Dr. Sieck joined the
faculty in the Department of Biomedical Engineering at the University of Southern California
where he remained until 1990 when he moved to Mayo Clinic.Dr. Sieck served as President of
the American Physiological Society (2009-2011) and President of the Association of Chairs of
Departments of Physiology (2010-2012). He is a founding Fellow of the American Physiological
Society, and an elected Fellow of the American Institute of Medical and Biological Engineering.
In the past, he 
served as editor-in- chief of the Journal of Applied Physiology from 1999-2005,
and he 
is currently editor-in- chief of Physiology. Dr. Sieck has also served on several study
sections at the National Institutes of Health (NIH). He has also served as a mentor for 21Ph.D.
students, 71 postdoctoral fellows and 17 visiting scientists.Dr. Sieck’s research focuses on the
neural control of respiratory muscles including the diaphragm and airway smooth muscle. He has
published more than 365 peer-reviewed papers, and his research has been continuously funded
by multiple grants from the NIH for more than 35 years.

Mayo Clinic, Rochester, Minesotta, USA

Hugh Montgomery

​Hugh Montgomery obtained a 1st Class BSc in Cardiorespiratory Physiology/ Neuropharmacology in 1984, and graduated from the Middlesex Hospital Medical School in 1987.  He has since completed higher specialist training in Cardiology, General Internal Medicine and Intensive Care Medicine. He is Professor of Intensive Care Medicine at University College London, where he directs the Centre for Human Health and Performance. He has published over 280 scientific papers. He also works as a consultant intensivist at the Whittington Hospital in N London.

University College Hospital London, UK

Ross Breckenridge

Ross studied Medical Sciences at Cambridge University, then qualified in clinical medicine from Oxford University Medical School. He completed a PhD in cardiac development at the Wellcome/CRUK Institute at Cambridge and went on to train in Clinical Pharmacology at University College London, where he is now a consultant physician and Director of the London Clinical Pharmacology Training Programme. Ross has 15 years experience as a consultant to investment funds. He currently sits on the Board of Directors of REVA Medical Inc., San Diego and Silver Creek Pharmaceuticals, San Francisco.

University College Hospital London, UK

Asma Khalil

Asma Khalil is a consultant obstetrician at St George's Hospital and honorary senior lecturer at St George's Medical School, University of London. She is a subspecialist in Maternal and Fetal Medicine. She is lead for the Multiple Pregnancy service at St George's Hospital, the referral unit for the South West London region. She gained her MD at the University of London in 2009. She also has a Masters degree in Epidemiology from the London School of Hygiene & Tropical Medicine and an MRC scholarship. She has published more than 50 peer reviewed papers, and many published review articles and chapters. She was awarded many research prizes, both at national and international meetings. 

St George's Hospital London, UK

Mario Manto

Prof. Mario Manto, MD, PhD, is neurologist at ULB-Erasme (Brussels, Belgium) and permanent researcher at the FNRS-Belgium. He is associate professor at the University of Mons, Belgium. He focuses his research on cerebellar disorders in human and in animals.

FNRS-Laboratoire de Neurologie Expérimentale Hôpital Erasme, Université Libre de Bruxelles Brussels Belgium

Please reload


Adam Deane

He completed his MBBS at the University of Melbourne before commencing clinical training in Internal Medicine and then Intensive Care Medicine at St. Vincent’s Hospital, Melbourne. Adam subsequently completed a clinical fellowship at the John Radcliffe Hospital, Oxford (UK), before moving to Adelaide in 2007 to pursue a PhD, which was conferred in 2012.

Adam is an Intensive Care Clinician/Scientist who migrated to Adelaide to undertake his PhD programme through the University of Adelaide/Royal Adelaide Hospital. He has a particular interest in glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which are secreted by the small intestine and are pivotal in regulating glucose metabolism.
Adam has received numerous grants and awards and has a track record for publishing innovative research (publications). He also frequently presents at national and international meetings (presentations).
He is passionate about informing medical students and intensive care trainees about the joys of clinical research. His research interests are broad-based but predominately clinical and focus on critical illness, diabetes, nutrition and gastrointestinal function.

Deputy Director ICU| Head of ICU Research The Royal Melbourne Hospital – City Campus | Intensive Care Unit

Olaf Stuve

Dr. Olaf Stuve is a Professor in the Department of Neurology and Neurotherapeutics at UT Southwestern Medical Center in Dallas, and Chief of Neurology at the VA North Texas Health Care System/ Dallas VA Medical Center.  In addition to his clinical activities, he has been the site Principal Investigator and Consultant for numerous clinical trials.  He also runs a research laboratory at UT Southwestern.  His research interests include molecular and cellular markers of autoimmunity, immune tolerance, and experimental therapies for autoimmune disorders, and he has numerous ongoing collaborations with national and international investigators.  He has mentored undergraduate students, graduate students, medical students, residents, and post-doctoral fellows.

Dr. Stuve’s research has been supported by grants from the Department of Veterans Affairs, the National Multiple Sclerosis Society (NMSS), the Deutsche Forschungsgemeinschaft (DFG), Boehringer Ingelheim Fonds, and the Doris Duke Charitable Foundation.  He has published over 200 research articles, review articles, editorials, and book chapters.  Dr. Stuve is a fellow of the American Neurological Association (FANA), and the American Academy of Neurology (FAAN). He is an elected member of the Alpha Omega Alpha (AOA) Honor Medical Society.  Dr. Stuve has received numerous clinical teaching awards.  He has served on numerous editorial boards of medical and scientific journals, and has been a member of National Institutes of Health (NIH), and NMSS study sections.  Dr. Stuve is a past associate editor of JAMA Neurology, and a past steering committee member of the Immune Tolerance Network (ITN).

He received his medical degree from the Free University of Berlin, completed a medical doctoral thesis in physiology at the Max Delbruck Center for Molecular Medicine in Berlin magna cum laude, and earned a Ph.D. in immunology in the Department of Clinical and Experimental Immunology at Maastricht University.  He completed a transitional internship at the University of Cape Town, and a preliminary internship and neurology residency at the University of Washington in Seattle.  Dr. Stuve also received postdoctoral fellowship training in neuroimmunology at McGill University in Montreal, and at the University of California, San Francisco (UCSF).

Veterans Affairs North Texas, Dallas, Texas, USA

Gavin Giovannoni

Gavin Giovannoni was appointed to the Chair of Neurology, Barts and The London School of Medicine and Dentistry, in November 2006. Gavin did his undergraduate medical training in South Africa. He moved to the Institute of Neurology, Queen Square, in 1993 where he did a PhD in Neuroimmunology.

Barts and The London Institute, London, UK

Cris Constantinecsu

Cris Constantinescu graduated with an MD from Boston University School of Medicine in 1988 and then, as recipient of physician-scientist award from the National Institutes of Health, USA, completed a PhD in Immunology at the University of Pennsylvania in 1998, with a thesis exploring the role of IL-12 in immune responses in the central nervous system. He completed an internship, residency in Neurology and Fellowships in Neuroimmunology and Neurorehabilitation. He held
positions in Neurology (MS Clinic) and Neurobiology at the University of Basel, Switzerland in 1997-1998 and in Immunology at the University of Leicester in 1999, 
United Kingdom, before being appointed Honorary Consultant Neurologist and Senior Lecturer in Neurology at University of Nottingham in 2000-2001. In 2004 he was appointed Chair in Neurology at University of Nottingham.
His research interests are immune regulation in inflammatory diseases of the nervous system, 
in particular MS and its models, imaging in MS, clinical trials, and epidemiology. He runs a busy, large MS Clinic together with 4 other clinical neurologists in Nottingham. He is the clinical lead for neurological diseases in the East Midlands Clinical Research Network.

University of Nottingham Nottingham, UK

Toral Patel

UT Southwestern, Medical Center

Dallas, Texas, USA

Toral Patel, M.D., is an Assistant Professor of Neurological Surgery at UT Southwestern Medical
where she specializes in brain tumor surgery.
Dr. Patel received her undergraduate degree in biomedical engineering from Johns Hopkins
University and earned her medical degree at UT Southwestern Medical School. She completed a
residency in neurological surgery at Yale-New Haven Hospital. She then completed a fellowship in
neurosurgical oncology at Memorial Sloan Kettering Cancer Center, before returning to UT
Southwestern as a faculty member in 2014.

Dr. Patel’s clinical and research interests are focused on the treatment of malignant brain tumors. In particular, her research relates to the development of novel drug delivery systems for the central nervous system.
Dr. Patel is a member of the Society for Neuro-Oncology, the Congress of Neurological Surgeons,
and the American Association of Neurological Surgeons.

Please reload